1. Introduction
Gingivitis is an inflammatory process caused by the presence of bacteria, which, starting from the gingival margin, can also spread to the rest of the gum [1,2,3]. Even when bacterial plaque levels are minimal, the immune system reacts by triggering an inflammatory response that determines the presence of infiltrate [4]. As reported by several studies, sites affected by previous periodontal disease, unlike healthy sites, have a greater predisposition to the onset of gingivitis [5,6,7]. The immune response, in the presence of systemic pathologies of a blood, endocrine, autoimmune and neoplastic nature, may undergo alterations that affect the development of both gingivitis and other oral manifestations of systemic diseases [8,9,10]. The main clinical manifestations of gingivitis are gingival redness, bleeding, and edema [11] not associated with periodontal attachment loss [12]. Since gingivitis does not always cause pain, and the manifestations can be exclusively subclinical, except in rare cases of spontaneous bleeding, an early diagnosis can be difficult [13]. The main cause of the onset of this pathology is considered insufficient oral hygiene [14]; however other possible factors such as smoking [15], genetic alterations [16], systemic diseases of bacterial, viral or fungal origin [17,18,19], autoimmune diseases [20] or of endocrine origin [21], neoplasms [22] and lesions traumatic [23], can promote inflammation of the periodontal support tissues. Although the forms of gingivitis not induced by plaque are not expressly caused by bacterial bioflim, their severity and progression can be influenced by the accumulation of the plaque and the consequent subgingival inflammation [14,24]. The plaque-induced gingivitis treatment protocols provide for the reduction of the etiological agent, that is, the plaque itself, with a consequent progressive improvement of the patient’s oral health conditions, progressively reducing the symptoms associated with the pathology [25,26,27,28]. The aim of this therapy, regardless of the method chosen, is to avoid the progression of bacteria in the subgingival region, involving the connective tissue and the alveolar bone and thus determining the evolution of gingivitis in periodontitis [29,30]. Although the onset of periodontal disease consists of considerable inter-individual variability and depends on various predisposing factors, plaque accumulation represents the main risk factor in the transition between gingivitis and periodontitis [31,32]. The traditional method of treating gingivitis involves the association of mechanical instrumentation with the use of chemical agents with antiseptic action, with the aim, not only of removing the bacterial plaque, but also of guiding the patient in a correct hygienic maintenance therapy, both at home and professionally [33]. Laser treatment has been proposed as a possible therapeutic alternative or in combination with conventional therapy [34,35]. As reported by several studies, the diode laser has provided excellent results in nonsurgical periodontal therapy, demonstrating a bactericidal effect [36,37]. Diode lasers having a wavelength of 980 nanometres and a power of 2 watts have a photodestructive effect, causing the elimination of the periodontal pathogenic microflora [38] Absorption of laser light leads to elevated tissue temperatures, as a result of which most bacteria, including anaerobes, are readily inactivated [39]. Furthermore, compared to traditional mechanical instruments, it allows easier access to areas otherwise difficult to access [40]. The aim of this study was to evaluate and compare two different techniques for the treatment of plaque-induced gingivitis, demonstrating whether the diode laser-assisted causal therapy can allow a resolution of the edema caused by gingivitis in less time than traditional single causal therapy.
2. Materials and Methods 2.1. Sample Composition The present pilot study was conducted on a sample of 25 patients, aged between twenty and sixty years. All patients were recruited from the CLID oral hygiene department within the Scientific Hospitalization and Care Institute, San Raffaele Hospital. The sample was made up of specially selected individuals with a specific diagnosis of gingivitis. The study protocol was approved by the Local Ethics Committee, Milan, no. PR246 and written informed consent was obtained from all study participants in accordance with the Helsinki Declaration. 2.2. Inclusion Criteria In order to participate in the study, patients in good health, free of oral and periodontal systemic diseases, were selected. Left-handed patients were excluded. The whole sample must have completed any drug therapy with antibiotics and anti-inflammatories at least two weeks before participating in the study. Patients with a specific diagnosis of nonplaque-induced gingivitis were also excluded (1,4,5):
- Inflammation caused by systemic factors; a typical example is represented by pregnancy or by hormonal upheavals such as puberty or menstruation.
- Phlogistic-hyperplastic alterations in conjunction with the intake of antiepileptics, calcium channel blockers, and cyclosporine.
- Gingivitis caused by the use of oral contraceptives.
- Gingivitis modified by systemic diseases.
- Gingivitis affecting patients with diabetes mellitus.
- Gingivitis associated with disorders of the blood picture (e.g., leukemia).
- Plaque gingivitis modified by malnutrition, such as chronic deficiency of vitamins A, C, and D (although they seem to occur rarely in Europe).
2.3. Procedure
The participants were informed about the methods of the experimental study and about the objectives and purposes of the latter. Subsequently, before proceeding, patients had to sign the Informed Consent, in which the protocol was accurately described. Clinical parameters (bleeding index, plaque index, recession, and clinical attachment level) were initially evaluated and recorded in all patients. The standard parameters of plaque index, bleeding index, etc. were evaluated to exclude that the patient could have periodontal disease through the PSR Periodontal Screening and Recording), which consists of a simplified registration of clinical findings. With the PSR, in fact, all the sites of all the dental elements are explored with a periodontal probe, after completing the anamnestic surveys. A first intraoral scan prior to therapy was then performed, which consists of a reference scan; this was repeated at twenty minutes, after having made the patient rinse with 0.2% CHX (T0). Each of them was subjected to the professional oral hygiene session, and through a split-mouth protocol, for each individual patient, they were chosen by simple randomization which hemi-arches to treat with causal therapy assisted by the action of the diode laser (experimental therapy) and which with traditional causal therapy (control therapy). At the end of the session, each individual patient was instructed on correct home oral hygiene procedures. Subsequently, a control scan was performed 7 days after the session (T1) and 14 days (T2), during which the clinical indexes were resumed. For the clinical application of tissue biostimulation, the Raphael Laser (Figure 1), a medical device classified II b (according to Annex IX of the Directive 93/42/EEC).
The diode laser protocol has been the subject of study at our university center, Vita Salute San Raffaele; the study protocol concerns the Raphael diode laser (BIO 980 DMT S.r.l.-Italy: verified and calibrated by the manufacturer has been used in all cases, operating at a wavelength of 940 nm). The laser works continuously with a 3003−3020 μm optical fiber connected to a probe with an output surface of 0.5 cm2, capable of emitting a collimated Gaussian beam with very low divergence. The instrument has been positioned at 12−mm perpendicular to the site, thus reducing reflection bias. The movement is defined as “lawn mowing” in the apico-coronal direction. The application time of 80 s for each site and output power set to 2−3.5 W, average fluency of 10 J/cm2 and average power density (at the target) was 0.125 W/cm2 with a cumulative density dose of 20 J per site for each treatment (max n. of treatment 4 × 20 J = 80 J). For each intraoral scan, the CS 3600 intraoral scanner from Carestream Dental was used by the dentist. CS 3600 has been designed to acquire 3D still images in the following ways:
- mandible
- maxilla
- buccal occlusal registration
The CS 3600 system adopts the following software: Imaging software (CS orthodontic imaging) and CS 3600 acquisition interface. The CS 3600 acquisition interface has made it possible to acquire images in two ways:
- Partial scan of the arch: several teeth in the preparation area on the mandible and maxilla, and a buccal occlusal registration.
- Complete scan of the arch: maxilla, mandible and buccal occlusal registration.
2.4. Statistic Analysis The collected data were processed in double-blind since the operator who carried out the static and volumetric analyzes was not aware of the group belonging to the data deriving from the patients. These data were then statistically compared in order to detect any differences between the volumetric variations and through the analysis of the gingival-periodontal health parameters between the two therapy groups and within the therapy groups over time. The normality of the distribution was tested by Shapiro–Wilk test, and given the non-normality of the data distribution, nonparametric methods were applied. The statistical analyzes were then performed by comparing the two therapy groups with the Mann–Whitney test and the effectiveness of the therapy between T0 and T2 using Friedman’s test. 2.5. Treatment of the Collected Data Once the scans were collected, they were selected to carry out the analysis, the pre-treatment scan (T1), and the scan performed after two weeks (T2). First, all the detected scans that were presented in STL format were imported into the data management software. The STL files were imported into a scanning software: Optical Revenge Dental 5.0.
Once imported, both scans obtained simultaneously from the same mouth in half-arches were divided (Figure 2), creating a section that includes the elements of the rear portions.
In this way, the operator obtained four hemi-arches from each individual scan. Once these sections are obtained, the sectoral alignment by hemi-arch is followed so as to be able to proceed with the volumetric analysis. This operation allowed the alignment of two sections of the same subject which takes place automatically (Figure 3) by the software after the operator, having inserted a second scan, gives the command to align the second scan on that previously imported; subsequently, it was also optimized manually (Figure 4) through the choice of landmarks.
In this second phase, hard tissues were used as reference points.
Once superimposed, the images were associated with the same two different colors (Figure 4) to perform a first visual analysis: the most similar files had alternating colors. The files that instead differed totally, or in part, showed big discrepancies, so one color prevailed over the other.
After the alignment procedure, cleaning operations were carried out (mesh cleaning) to delimit the area to be analyzed.
In order to create a solid for each individual impression and perform an evaluation as detailed as possible, the Exocad Model Creator program was used. It allowed to use a fixed surface (Figure 5) as the base of the section, and the impressions, once the cleaning operation was carried out, were positioned parallel to the surface.
This step was made for the sections of both scans so that the two sections presented the exact same distance at the highest point. In this way, the STL files that were previously open have been closed (Figure 6 and Figure 7).
This procedure was necessary to make the two sections completely superimposable in order to continue with the volumetric analysis.
Finally, the files were imported (Figure 8) into the Geomagic Studio 13 software. It was possible to calculate the volume in cubic millimeters, having established the millimeter as the unit of measurement. Having thus had both numerical values available, it was possible to calculate the difference between the two values.
In conclusion, a colorimetric evaluation was performed through a special analysis tool that made it possible to evaluate the volume using the colorimetric scale. This analysis tool used the micron as the reference unit of measurement and made it possible to evaluate the volume of an area or of the whole section through the colorimetric scale (Figure 9) which involves the use of three colors: light blue/blue when the volume is lower, green when the volume is identical for both sections, yellow/red when the volume is higher.
To perform all these evaluations, however, it was necessary that the files were as similar as possible. For this purpose, sections of the scans obtained have been created. 3. Results
The collected data were statistically compared in order to detect any differences between the volumetric variations between the two therapy groups and within the therapy groups over time. Statistical comparisons regarding the analysis of PI and BoP parameters are illustrated in Table 1 and Table 2.
Table 1 and Table 2 PI and BOP parameters reported as median, interquartile, mean, and standard deviation of the percentage values and statistical comparison of the two groups. As regards the volumetric analysis, in the same way, there is no statistically significant difference between the volumetric variations of the laser and the control group compared to T0, T1, and T2 (Figure 10, Figure 11 and Figure 12).
After evaluating the distribution of data through the Kolmogorov–Smirnov statistical test, the appropriate nonparametric tests were chosen to carry out the statistical comparisons. Given certain values for each patient, no significant differences were found in the comparison between the two therapy groups. On the basis of the analysis of the gingival–periodontal health parameters and the volumetric value of the treated areas, no statistically significant differences were detected between the areas treated with the adjuvant action of the diode laser compared to those treated with causal therapy alone. 4. Discussion
The periodontium includes the following tissues: gingiva, periodontal ligament, root cement, alveolar bone (subdivided into proper alveolar bone and alveolar process) [41]. The gingiva is the portion of chewing mucosa that covers the alveolar process and surrounds the collar of the teeth [42].
Gingivitis is an inflammatory process caused by the presence of bacteria, which starting from the gingival margin, can also spread to the rest of the gum [1,2,3]. The consideration of gingivitis at the implants is called mucositis [43]. Both gingivitis and mucositis, although they are reversible processes, if left untreated, can evolve into an irreversible process of destruction of the periodontal attachment, respectively called gingivitis and peri-implantitis [44,45].
The task of the dentist and dental hygienist is to monitor the patient so as to avoid progression or any recurrence of these pathologies, restoring a state of health of the tooth support tissues and allowing the success of implant-prosthetic rehabilitations over time [46,47,48,49,50].
The intensity of clinical signs and symptoms of gingival inflammation can vary both between different individuals and between sites in the same mouth [31,32]. Normally, the clinical outcomes of plaque-induced gingivitis include erythema, edema, gingival bleeding, and sensitivity [51]. The plaque-induced gingivitis treatment protocols provide for the reduction of the etiological agent, that is, the plaque itself, with a consequent progressive improvement of the patient’s oral health conditions, progressively reducing the symptoms associated with the pathology [33]. Laser treatment has been proposed as a possible therapeutic alternative to traditional mechanical instrumentation associated with the use of chemical agents with an antiseptic action or in association with conventional therapy [34,35].
The diode laser is a semiconductor. The wavelengths of diode lasers most commonly used in dentistry range from 610 to 980 nanometers. It can work in both continuous and intermittent wave (PW) modes. When interacting with the surface of the fabric, the laser light can be refracted, diffused, absorbed, or transmitted. The laser energy absorbed by the tissues can cause heating, coagulation, or vaporization effects depending on the wavelength, power, and optical properties of the tissue [36]. As part of the treatment of periodontal disease, several studies have shown that the use of the laser, if associated with the traditional scaling and root planing method, has provided better clinical and immunological results than conventional therapy [35,52,53,54,55,56,57]. As reported by several authors, since diode laser light is highly absorbed in the hemoglobin of the blood, the laser could represent an effective choice in the removal of highly vascularized inflamed tissues of the periodontal pocket [58]
In reality, compared to what has been shown by the studies mentioned above, the literature is controversial: as reported by several authors, the diode laser, associated with the traditional method, does not provide statistically significant results in microbiological terms and the reduction of clinical signs of gingival inflammation [48,49,50]. In addition, complications such as damage to the supporting tissues due to overheating of the same can be associated with the use of the laser. As reported by several authors, at a temperature above 10 for more than a minute of treatment, damage to the alveolar bone and periodontal ligament can be found, with consequent ankylosis of the dental element and bone resorption [59].
5. Conclusions With the limitations of this study, such as the possible inter-individual variability in terms of compliance, in accordance with the statistical results obtained, diode laser therapy does not allow a faster resolution of gingival edema compared to traditional therapy; the two treatment techniques for plaque-induced gingivitis, therefore, have the same efficacy. Further studies are needed to confirm the results obtained.
Figure 10. Box and whisker plot representing the performance of the control group at T0, T1, and T2.
Figure 11. Box and whisker plot representing the progress of the laser unit at T0, T1, and T2.
Figure 12. Graphic representation in which the two therapy groups (laser and control) are compared.
Group 1 | Procedures | PI MEDIAN (IQR) | BOP MEDIAN (IQR) |
---|---|---|---|
T0 | LASER | 61 (50–82) | 33 (28–55) |
CONTROL | 60 (48–83) | 35 (29–55) | |
T1 | LASER | 10 (8–12) | 3 (0–6) |
CONTROL | 10 (8–12) | 3 (1–6) | |
T1–T0 | LASER | −53 (−70–39) | −33 (−50–27) |
CONTROL | −51 (−70–36) | −31 (−49–28) | |
T2 | LASER | 10 (9–13) | 0 (0–82) |
CONTROL | 11 (10–13) | 3 (1–6) | |
T2–T1 | LASER | 1(0–2) | 3 (0–6) |
CONTROL | 1(0–1) | 0 (0–1) |
Group 2 | Procedures | PI MEAN (SD) | BOP MEAN (SD) | p-Value |
---|---|---|---|---|
T0 | LASER | 67.32 (22) | 46.76 (29.14) | n.s. |
CONTROL | 68.48 (22.39) | 46.96 (29.09) | ||
T1 | LASER | 11.64 (6.68) | 4 (5.08) | n.s. |
CONTROL | 12.16 (6.54) | 4.84 (5.26) | ||
T1–T0 | LASER | −0.56 (0.18) | −0.43 (0.26) | n.s. |
CONTROL | −0.54 (−0.19) | −0.42 (0.25) | ||
T2 | LASER | 12.76 (7.57) | 67.32 (22) | n.s. |
CONTROL | 13.16 (7.40) | 5.20 (5.35) | ||
T2–T1 | LASER | 0.01 (0.02) | −0.43 (0.26) | n.s. |
CONTROL | 0.01 (0.02) | 0.00 (0.01) |
Author Contributions
E.P., F.F. thought about the idea; C.T. and B.S. collected the data; G.T. wrote the manuscript; G.G., E.P. revised the manuscript. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Conflicts of Interest
All the authors declare that there are no conflict of interest regarding the publication of this paper.
1. Löe, H.; Theilade, E.; Jensen, S.B. Experimental gingivitis in man. J. Periodontol. 1965, 36, 177-187.
2. Theilade, E.; Wright, W.H.; Jensen, S.B.; Löe, H. Experimental gingivitis in man. II. A longitudinal clinical and bacteriological investigation. J. Periodontal Res. 1966, 1, 1-13.
3. Trombelli, L.; Tatakis, D.N.; Scapoli, C.; Bottega, S.; Orlandini, E.; Tosi, M. Modulation of clinical expression of plaque-induced gingivitis. II. Identification of "high-responder" and "low-responder" subjects. J. Clin. Periodontol. 2004, 31, 239-252.
4. Lang, N.P.; Bartold, P.M. Periodontal health. J. Periodontol. 2018, 89 (Suppl. 1), S9-S16.
5. Kinane, D.F. Periodontitis modified by systemic factors. Ann. Periodontol. 1999, 4, 54-64.
6. Zmora, N.; Bashiardes, S.; Levy, M.; Elinav, E. The role of the immune system in metabolic health and disease. Cell Metab. 2017, 25, 506-521.
7. Capparé, P.; Teté, G.; Romanos, G.E.; Nagni, M.; Sannino, G.; Gherlone, E.F. The 'All-on-four' protocol in HIV-positive patients: A prospective, longitudinal 7-year clinical study. Int. J. Oral. Implantol. 2019, 12, 501-510.
8. American Academy of Periodontology. Parameter on plaque-induced gingivitis. J. Periodontol. 2000, 71 (Suppl. 5), 851-852.
9. Löe, H.; Anerud, A.; Boysen, H.; Morrison, E. Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J. Clin. Periodontol. 1986, 13, 431-445.
10. Ismail, A.I.; Morrison, E.C.; Burt, B.A.; Caffesse, R.G.; Kavanagh, M.T. Natural history of periodontal disease in adults: Findings from the Tecumseh Periodontal Disease Study, 1959-1987. J. Dent. Res. 1990, 69, 430-435.
11. Li, Y.; Lee, S.; Hujoel, P.; Su, M.; Zhang, W.; Kim, J.; Zhang, Y.P.; DeVizio, W. Prevalence and severity of gingivitis in American adults. Am. J. Dent. 2010, 23, 9-13.
12. Murakami, S.; Mealey, B.L.; Mariotti, A.; Chapple, I.L.C. Dental plaque-induced gingival conditions. J. Periodontol. 2018, 89 (Suppl. 1), S17-S27.
13. Blicher, B.; Joshipura, K.; Eke, P. Validation of self-reported periodontal disease: A systematic review. J. Dent. Res. 2005, 84, 881-890.
14. Tecco, S.; Sciara, C.; Pantaleo, G.; Nota, A.; Visone, A.; Germani, S.; Polizzi, E.; Gherlone, E.F. The association between minor recurrent aphthous stomatitis (RAS), children's poor oral condition, and underlying negative psychosocial habits and attitudes towards oral hygiene. BMC Pediatr. 2018, 18, 136.
15. AlJehani, Y.A. Risk factors of periodontal disease: Review of the literature. Int. J. Dent. 2014, 2014, 182513.
16. Hart, T.C.; Gorry, M.C.; Hart, P.S.; Woodard, A.S.; Shihabi, Z.; Sandhu, J.; Shirts, B.; Xu, L.; Zhu, H.; Barmada, M.M.; et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and famil- ial juvenile hyperuricaemic nephropathy. J. Med. Genet. 2002, 39, 882-892.
17. Katz, J.; Guelmann, M.; Rudolph, M.; Ruskin, J. Acute streptococcal infection of the gingiva, lower lip, and pharynx-A case report. J. Periodontol. 2002, 73, 1392-1395.
18. Parisi, M.R.; Tecco, S.; Gastaldi, G.; Polizzi, E.; D'Amicantonio, T.; Negri, S.; Gardini, I.; Schlusnus, K.; Gherlone, E.; Capparè, P.; et al. Point-of-care testing for hepatitis C virus infection at alternative and high-risk sites: An Italian pilot study in a dental clinic. New Microbiol. 2017, 40, 242-245.
19. Scully, C.; Epstein, J.; Porter, S.; Cox, M. Viruses and chronic disorders involving the human oral mucosa. Oral Surg. Oral Med. Oral Pathol. 1991, 72, 537-544.
20. Stone, S.J.; McCracken, G.I.; Heasman, P.A.; Staines, K.S.; Pennington, M. Cost-effectiveness of personalized plaque control for managing the gingival manifestations of oral lichen planus: A randomized controlled study. J. Clin. Periodontol. 2013, 40, 859-867.
21. Albandar, J.M.; Susin, C.; Hughes, F.J. Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: Case definitions and diagnostic considerations. J. Periodontol. 2018, 89 (Suppl. 1), S183-S203.
22. Napier, S.S.; Speight, P.M. Natural history of potentially malignant oral lesions and conditions: An overview of the literature. J. Oral. Pathol. Med. 2008, 37, 1-10.
23. Rawal, S.Y.; Claman, L.J.; Kalmar, J.R.; Tatakis, D.N. Traumatic lesions of the gingiva: A case series. J. Periodontol. 2004, 75, 762-769.
24. Eberhard, J.; Grote, K.; Luchtefeld, M.; Heuer, W.; Schuett, H.; Divchev, D.; Scherer, R.; Schmitz-Streit, R.; Langfeldt, D.; Stumpp, N.; et al. Experimental gingivitis induced systemic inflammatory markers in young healthy individuals: A single-subject interventional study. PLoS ONE 2013, 8, e55265.
25. Badersten, A.; Nilveus, R.; Egelberg, J. Effect of nonsurgical periodontal therapy. II. Severely advanced periodontitis. J. Clin. Periodontol. 1984, 11, 63-76.
26. Badersten, A.; Nilvéus, R.; Egelberg, J. Effect of nonsurgical periodontal therapy. I. Moderately advanced periodontitis. J. Clin. Periodontol. 1981, 8, 57-72.
27. Kaldahl, W.B.; Kalkwarf, K.L.; Patil, K.D.; Molvar, M.P.; Dyer, J.K. Long-term evaluation of periodontal therapy: I. Response to 4 therapeutic modalities. J. Periodontol. 1996, 67, 93-102.
28. Chapple, I.L.; Van der Weijden, F.; Doerfer, C.; Herrera, D.; Shapira, L.; Polak, D.; Madianos, P.; Louropoulou, A.; Machtei, E.; Donos, N.; et al. Primary prevention of periodontitis: Managing gingivitis. J. Clin. Periodontol. 2015, 42 (Suppl. 16), S71-S76.
29. Agerbaek, N.; Melsen, B.; Lind, O.P.; Glavind, L.; Kristiansen, B. Effect of regular small group instruction per se on oral health status of Danish schoolchildren. Community Dent. Oral Epidemiol. 1979, 7, 17-20.
30. Ramseier, C.A.; Anerud, A.; Dulac, M.; Lulic, M.; Cullinan, M.P.; Seymour, G.J.; Faddy, M.J.; Bürgin, W.; Schätzle, M.; Lang, N.P. Natural history of periodontitis: Disease progression and tooth loss over 40 years. J. Clin. Periodontol. 2017, 44, 1182-1191.
31. Albandar, J.M.; Kingman, A.; Brown, L.J.; Löe, H. Gingival inflammation and subgingival calculus as determinants of disease progression in early-onset periodontitis. J. Clin. Periodontol. 1998, 25, 231-237.
32. Serrano, J.; Escribano, M.; Roldán, S.; Martín, C.; Herrera, D. Efficacy of adjunctive anti-plaque chemical agents in managing gingivitis: A systematic review and meta-analysis. J. Clin. Periodontol. 2015, 42 (Suppl. 16), S106-S138.
33. Calderini, A.; Pantaleo, G.; Rossi, A.; Gazzolo, D.; Polizzi, E. Adjunctive effect of chlorhexidine antiseptics in mechanical periodontal treatment: First results of a preliminary case series. Int. J. Dent. Hyg. 2013, 11, 180-185.
34. Caruso, U.; Nastri, L.; Piccolomini, R.; d'Ercole, S.; Mazza, C.; Guida, L. Use of diode laser 980 nm as adjunctive therapy in the treatment of chronic periodontitis. A randomized controlled clinical trial. New Microbiol. 2008, 31, 513-518.
35. Harris, D.M.; Yessik, M. Therapeutic ratio quantifies laser antisepsis: Ablation of Porphyromonas gingivalis with dental lasers. Lasers Surg. Med. 2004, 35, 206-213.
36. Coluzzi, D.J. Fundamentals of lasers in dentistry: Basic science tissue interaction and instrumentation. J. Laser Dent. 2008, 16, 4-10.
37. Gutknecht, N.; Apel, C.; Bradley, P.; de Paul Eduardo, C.; Featherstone, J. Proceedings of the 1st International Workshop of Evidence Based Dentistry on Lasers in Dentistry; Quintessence Pub. Co.: London, UK; Chicago, IL, USA, 2008; pp. 166-167, 207-210.
38. Moritz, A.; Schoop, U.; Goharkhay, K.; Schauer, P.; Doertbudak, O.; Wernisch, J.; Sperr, W. Treatment of periodontal pockets with a diode laser. Lasers Surg. Med. 1998, 22, 302-311.
39. Cobb, C.M.; Low, S.B.; Coluzzi, D.J. Lasers and the treatment of chronic periodontitis. Dent. Clin. N. Am. 2010, 54, 35-53.
40. Ishikawa, I.; Aoki, A.; Takasaki, A.A.; Mizutani, K.; Sasaki, K.M.; Izumi, Y. Application of lasers in periodontics: True innovation or myth? Periodontology 2000 2009, 50, 90-126.
41. Linde, J.; Nikolaus, P.L. Parodontologia Clinica ed Implantologia Orale-Sesta Edizione, 2016; Edi.Ermes: Milano, Italy, 2016; pp. 34-39.
42. Schroeder, H.E.; Listgarten, M.A. The gingival tissues: The architecture of periodontal protection. Periodontology 2000 1997, 13, 91-120.
43. Zitzmann, N.U.; Berglundh, T. Definition and prevalence of peri-implant diseases. J. Clin. Periodontol. 2008, 35, 286-291.
44. Lang, N.P.; Schätzle, M.A.; Löe, H. Gingivitis as a risk factor in periodontal disease. J. Clin. Periodontol. 2009, 36 (Suppl. 10), 3-8.
45. Costa, F.O.; Takenaka Martinez, S.; Costa, L.O.; Ferreira, S.D.; Silva, G.L.; Costa, J.L. Peri-implant disease in patients with and without preventive maintenance: A 5-year follow-up. J. Clin. Periodontol. 2012, 39, 173-181.
46. Wilkins, E.M. La Pratica Clinica Dell'Igienista Dentale. II Edizione Italiana, a Cura di Nardi, G.M. (2011); Ediotre Piccin Nuova Libraria: Padova, Italy, 2011; pp. 3-17.
47. Malchiodi, L.; Caricasulo, R.; Cucchi, A.; Vinci, R.; Agliardi, E.; Gherlone, E. Evaluation of Ultrashort and Longer Implants with Microrough Surfaces: Results of a 24- to 36-Month Prospective Study. Int. J. Oral Maxillofac. Implants 2017, 32, 171-179.
48. Vinci, R.; Teté, G.; Lucchetti, F.R.; Capparé, P.; Gherlone, E.F. Implant survival rate in calvarial bone grafts: A retrospective clinical study with 10 year follow-up. Clin. Implant. Dent. Relat. Res. 2019, 21, 662-668.
49. Agliardi, E.L.; Tetè, S.; Romeo, D.; Malchiodi, L.; Gherlone, E. Immediate function of partial fixed rehabilitation with axial and tilted implants having intrasinus insertion. J. Craniofac. Surg. 2014, 25, 851-855.
50. Maló, P.; Rigolizzo, M.; Nobre, M.; Lopes, A.; Agliardi, E. Clinical outcomes in the presence and absence of keratinized mucosa in mandibular guided implant surgeries: A pilot study with a proposal for the modification of the technique. Quintessence Int. 2013, 44, 149-157.
51. Mühlemann, H.R.; Son, S. Gingival sulcus bleeding-a leading symptom in initial gingivitis. Helv. Odontol. Acta. 1971, 15, 107-113.
52. Aykol, G.; Baser, U.; Maden, I.; Kazak, Z.; Onan, U.; Tanrikulu-Kucuk, S. The effect of low-level laser therapy as an adjunct to non-surgical periodontal treatment. J. Periodontol. 2011, 82, 481-488.
53. Saglam, M.; Kantarci, A.; Dundar, N.; Hakki, S.S. Clinical and biochemical effects of diode laser as an adjunct to nonsurgical treatment of chronic periodontitis: A randomized, controlled clinical trial. Lasers Med. Sci. 2014, 29, 37-46.
54. Kreisler, M.; Al Haj, H.; d'Hoedt, B. Clinical efficacy of semiconductor laser application as an adjunct to conventional scaling and root planing. Lasers Surg. Med. 2005, 37, 350-355.
55. Aoki, A.; Sasaki, K.M.; Watanabe, H.; Ishikawa, I. Lasers in nonsurgical periodontal therapy. Periodontology 2000 2004, 36, 59-97.
56. Ambrosini, P.; Miller, N.; Briancxon, S.; Gallina, S.; Penaud, J. Clinical and microbiological evaluation of the effectiveness of the Nd:Yap laser for the initial treatment of adult periodontitis. A randomized controlled study. J. Clin. Periodontol. 2005, 32, 670-676.
57. Assaf, M.; Yilmaz, S.; Kuru, B.; Ipci, S.D.; Noyun, U.; Kadir, T. Effect of the diode laser on bacteremia associated with dental ultrasonic scaling: A clinical and microbiological study. Photomed. Laser Surg. 2007, 25, 250-256.
58. Karlsson, M.R.; Diogo Löfgren, C.I.; Jansson, H.M. The effect of laser therapy as an adjunct to non-surgical periodontal treatment in subjects with chronic periodontitis: A systematic review. J. Periodontol. 2008, 79, 2021-2028.
59. Matys, J.; Grzech-Leśniak, K.; Flieger, R.; Dominiak, M. Assessment of an impact of a diode laser mode with wavelength of 980 nm on a temperature rise measured by means of k0-2 thermocouple: Preliminary results. Dent. Med. Probl. 2016, 53, 345-351.
Elisabetta Polizzi1, Giulia Tetè1,*, Claudia Targa2, Barbara Salviato3, Francesco Ferrini1,4 and Giorgio Gastaldi1,4
1Department of Dentistry, IRCCS San Raffaele Hospital, Vita Salute University, via Olgettina N.48, 20123 Milan, Italy
2Private Practice, Via Traversagno, 5, 45011 Adria, Italy
3Private Practice, Via Ponte Tresa, 31, 21031 Cadegliano-Viconago, Italy
4DDS, Dental School, Vita-Salute San Raffaele University, 20123 Milan, Italy
*Author to whom correspondence should be addressed.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Aim: The aim of this study was to evaluate and compare two different techniques for the treatment of plaque-induced gingivitis, demonstrating whether the causal therapy supported by diode laser can allow a resolution of the edema caused by gingivitis in less time compared to the single traditional causal therapy. Materials and methods: Twenty-five patients between 20 and 60 years of age with a specific diagnosis of gingivitis were evaluated at the CLID-HSR oral hygiene department. Once the clinical parameters (bleeding index, plaque index, recession, and clinical attack level) were recorded, each of them was subjected to a professional oral hygiene session and instructed in correct home hygiene procedures. Through a split-mouth protocol for each individual patient, hemi-arches were treated by simple randomization to be treated with causal therapy supported by the action of the diode laser (experimental therapy) and which with traditional causal therapy (control therapy). A first intraoral scan was performed before therapy (T0), which was repeated 20 min after rinsing with CHX. The intraoral scans were repeated at a control 7 (T1) and 14 days (T2) after the session. For each intraoral scan, a volumetric value was calculated, proportional to the edema of the gingival tissues, using special digital software. The operator who carried out the volumetric measurements on the software was not aware of the therapy implemented on each half-arch. The operator who carried out the statistical analysis was not aware of the therapy applied to each group. The collected data were statistically compared in order to detect any differences between the volumetric variations between the two therapy groups and within the therapy groups over time. After evaluating the distribution of data by means of the Kolmogorov-Smirnov statistical test, the appropriate nonparametric tests were chosen to carry out the statistical comparisons. Results: Based on the analysis of the gingival-periodontal health parameters and the volumetric value of the treated areas, no statistically significant differences were detected between the areas treated with the adjuvant action of the diode laser compared to those treated with causal therapy alone. Conclusions: With the limitations of this study, in accordance with the statistical results obtained, diode laser therapy does not allow a faster resolution of gingival edema compared to traditional therapy; the two treatment techniques for plaque-induced gingivitis, therefore, have the same efficacy.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer